The The Tennessee Star reports:

The Food and Drug Administration (FDA) says abortion providers are prescribing abortion-inducing drugs to women in advance of becoming pregnant – a practice that is without authorization and potentially dangerous for women.

“The FDA is concerned about the advance prescribing of mifepristone for this use,” an anonymous FDA spokesperson reportedly told the German-owned Politico Friday. “Mifepristone is not approved for advance provision of a medical abortion.”

The reported concerns of the FDA place the federal agency at odds with an abortion industry that has fiercely advocated for the lifting of restrictions on first-trimester abortion-inducing drugs, such as mifepristone and misoprostol. Abortion rights activists claimed such an easing was necessary during the pandemic so that women and girls could conduct their own abortions at home or in their college dorms after only a telemedicine chat with an abortion provider.

News Sources: